Theoretically, EGFR inhibition disfavors ferroptosis because MAPK signaling is required for ferroptosis, while its inhibition by EGFR or ERK inhibitors aborts the process of ferroptosis in lung cancer cells [42, 43]. The gene discussed is EGFR; the disease is lung carcinoma.